WebFeb 6, 2024 · Depression is a public health issue with significant unmet medical need. CAMBRIDGE, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: … WebApr 10, 2024 · Ovid Therapeutics Inc. Pfizer Inc. April 10 (Reuters) - Executives from more than 300 biotech and pharmaceutical industry companies, including Pfizer Inc (PFE.N) …
Biogen and Sage Therapeutics Announce FDA Accepts Filing of …
WebFeb 6, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 6, 2024-- Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and … WebDec 6, 2024 · Cambridge, Mass. – Dec. 6, 2024– Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics (Nasdaq: SAGE) announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). … google identity platform vs firebase auth
Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo …
WebFeb 16, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 16, 2024-- Sage Therapeutics, Inc. (Nasdaq: SAGE), and Biogen Inc. (Nasdaq: BIIB) today announced the CORAL Study in people with major depressive disorder (MDD) met the trial objectives, demonstrating a rapid and statistically significant reduction in depressive symptoms at … WebOct 3, 2024 · MEDIA CONTACTS: Biogen Dan Haro + 1 617 914 6936 [email protected] Denali Therapeutics Angela Salerno-Robin + 1 212 445 8219 [email protected] WebJun 14, 2010 · Together with Denali Therapeutics, we announced an agreement to develop and commercialize an antibody transport vehicle program targeting amyloid beta. Read more: biogen.com. Read the … google identity login